d-Cycloserine augmentation of cognitive remediation in schizophrenia
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
D-cycloserine (DCS) has been shown to enhance memory and, in a previous trial, once-weekly DCS improved negative symptoms in schizophrenia subjects. We hypothesized that DCS combined with a cognitive remediation (CR) program would improve memory of a practiced auditory discrimination task and that gains would generalize to performance on unpracticed cognitive tasks. Stable, medicated adult schizophrenia outpatients participated in the Brain Fitness CR program 3–5 times per week for 8 weeks. Subjects were randomly assigned to once-weekly adjunctive treatment with DCS (50 mg) or placebo administered before the first session each week. Primary outcomes were performance on an auditory discrimination task, the MATRICS cognitive battery composite score and the Scale for the Assessment of Negative Symptoms (SANS) total score. 36 subjects received study drug and 32 completed the trial (average number of CR sessions = 26.1). Performance on the practiced auditory discrimination task significantly improved in the DCS group compared to the placebo group. DCS was also associated with significantly greater negative symptom improvement for subjects symptomatic at baseline (SANS score ≥20). However, improvement on the MATRICS battery was observed only in the placebo group. Considered with previous results, these findings suggest that DCS augments CR and alleviates negative symptoms in schizophrenia patients. However, further work is needed to evaluate whether CR gains achieved with DCS can generalize to other unpracticed cognitive tasks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The molecular biology of memory storage: a dialogue between genes and synapses
Kandel, E. R. (2001) · Science · doi:10.1126/science.1067020 · Cited by 3,917
A Meta-Analysis of Cognitive Remediation for Schizophrenia: Methodology and Effect Sizes
Wykes, T., Huddy, V., Cellard, C., McGurk, S. R., & Czobor, P. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10060855 · Cited by 1,693
Ressler, K. J., Rothbaum, B. O., Tannenbaum, L., Anderson, P., Graap, K., Zimand, E., Hodges, L., & Davis, M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1136 · Cited by 1,063 · cited 2×
“…dose of 50mg has subsequently been demonstrated to improve negative symptoms and memory consolidation in schizophrenia subjects (Goff et al., 1999, 2008) and doses ranging from 50 to 500 mg improved response to CBT in individuals with anxiety disorders (Ressler et al., 2004; Norberg et al., 2008).”
BackgroundWalker, D. L., Ressler, K. J., Lu, K.-T., & Davis, M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-06-02343.2002 · Cited by 815
A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy
Norberg, M. M., Krystal, J. H., & Tolin, D. F. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.01.012 · Cited by 510 · cited 3×
“…dose of 50mg has subsequently been demonstrated to improve negative symptoms and memory consolidation in schizophrenia subjects (Goff et al., 1999, 2008) and doses ranging from 50 to 500 mg improved response to CBT in individuals with anxiety disorders (Ressler et al., 2004; Norberg et al., 2008).”
BackgroundEffects of D-Cycloserine on Extinction: Translation From Preclinical to Clinical Work
Davis, M., Ressler, K., Rothbaum, B. O., & Richardson, R. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.084 · Cited by 498
Wamsley, E. J., Tucker, M. A., Shinn, A. K., Ono, K. E., McKinley, S. K., Ely, A. V., Goff, D. C., Stickgold, R., & Manoach, D. S. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.08.008 · Cited by 492 · cited 2×
“, 2009), and these deficits are associated with diminished sleep spindles (Wamsley et al., 2012) and reduced PFC activation (Holt et al.”
BackgroundSelf-citationReconsolidation and Extinction of Conditioned Fear: Inhibition and Potentiation
Lee, J. L. C., Milton, A. L., & Everitt, B. J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2466-06.2006 · Cited by 479
Buchanan, R. W., Javitt, D. C., Marder, S. R., Schooler, N. R., Gold, J. M., McMahon, R. P., Heresco-Levy, U., & Carpenter, W. T. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06081358 · Cited by 419 · cited 1×
“The cut-off (SANS ≥ 20) used for this post hoc analysis has been used in prior studies, including the CONSIST trial (Goff et al., 1999; Buchanan et al., 2007).”
MethodConsolidation of Human Motor Cortical Neuroplasticity by D-Cycloserine
Nitsche, M. A., Jaussi, W., Liebetanz, D., Lang, N., Tergau, F., & Paulus, W. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300517 · Cited by 385 · cited 2×
“, 2008), and similar neuroplasticity is enhanced by DCS in healthy subjects (Nitsche et al., 2004).”
BackgroundAdrenergic transmission facilitates extinction of conditional fear in mice
Cain, C. K., Blouin, A. M., & Barad, M. (2004) · Learning & Memory · doi:10.1101/lm.71504 · Cited by 215 · cited 1×
“However, we do not view this failure to learn as a limitation in the present study, since sub-optimal learning protocols can be ideal for demonstrating nootropic drug effects (Walker et al., 2002; Cain et al., 2004).”
BackgroundQuartermain, D., Mower, J., Rafferty, M. F., Herting, R. L., & Lanthorn, T. H. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90687-4 · Cited by 190 · cited 3×
“DCS has been shown to enhance LTP and improve LTM in rodents after a single dose (Watanabe et al., 1992;Walker et al., 2002), however, tolerance develops with repeated dosing (Quartermain et al., 1994; Parnas et al., 2005).”
BackgroundExtinction memory is impaired in schizophrenia
Holt, D. J., Lebron-Milad, K., Milad, M. R., Rauch, S. L., Pitman, R. K., Orr, S. P., Cassidy, B. S., Walsh, J. P., & Goff, D. C. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.09.017 · Cited by 170 · cited 3×
“We have found deficits in fear extinction in subjects with schizophrenia (Holt et al., 2009; Holt et al., 2012), and numerous studies have demonstrated facilitation of fear extinction with DCS (Davis, 2011).”
BackgroundEffect on memory processing by D-cycloserine, an agonist of the NMDA/glycine receptor
Flood, J. F., Morley, J. E., & Lanthorn, T. H. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90709-d · Cited by 153 · cited 1×
“In healthy animals, DCS improves memory on a wide range of appetitive and aversive tasks (Flood et al., 1992; Quartermain et al., 1994; Matsuoka and Aigner, 1996; Parnas et al., 2005; Bailey et al., 2007).”
BackgroundGOFF, D., CATHER, C., GOTTLIEB, J., EVINS, A., WALSH, J., RAEKE, L., OTTO, M., SCHOENFELD, D., & GREEN, M. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.08.012 · Cited by 144 · cited 8×
“It is also consistent with our previous finding in schizophrenia subjects of enhanced recall of narrative themes on the Logical Memory Test (Goff et al., 2008).”
BackgroundMethodResultInfluentialSelf-citationSmits, J. A. J., Rosenfield, D., Otto, M. W., Powers, M. B., Hofmann, S. G., Telch, M. J., Pollack, M. H., & Tart, C. D. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.12.009 · Cited by 142 · cited 1×
“This interpretation is supported by recent studies of exposure therapy for anxiety, which demonstrate that DCS improves memory only when significant within-session learning is achieved (Smits et al., 2013a,b).”
ResultDysfunctional neural plasticity in patients with schizophrenia
Daskalakis, Z. J., Christensen, B. K., Fitzgerald, P. B., & Chen, R. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.4.378 · Cited by 130 · cited 3×
“An alternative approach aims to enhance neuroplasticity by exploiting the brain's inherent capacity to modify function in response to environmental demand, a process that appears to be impaired in schizophrenia (Daskalakis et al., 2008).”
BackgroundFailure of Neural Responses to Safety Cues in Schizophrenia
Holt, D. J., Coombs, G., Zeidan, M. A., Goff, D. C., & Milad, M. R. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.2310 · Cited by 121
Self-citationSmits, J. A. J., Rosenfield, D., Otto, M. W., Marques, L., Davis, M. L., Meuret, A. E., Simon, N. M., Pollack, M. H., & Hofmann, S. G. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.06.020 · Cited by 114 · cited 1×
“This interpretation is supported by recent studies of exposure therapy for anxiety, which demonstrate that DCS improves memory only when significant within-session learning is achieved (Smits et al., 2013a,b).”
ResultD-cycloserine facilitation of cognitive behavioral therapy for delusions in schizophrenia
Gottlieb, J. D., Cather, C., Shanahan, M., Creedon, T., Macklin, E. A., & Goff, D. C. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.05.029 · Cited by 73 · cited 1×
“Consistent with this explanation, in a recent cross-over trial of DCS augmentation of CBT for delusions, we found that DCS only enhanced efficacy if administered prior to the first CBT session (Gottlieb et al., 2011).”
ResultSelf-citationLangton, J. M., & Richardson, R. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.32 · Cited by 63 · cited 1×
“Further, in extinction studies DCS facilitates new learning only; if an animal has previously been trained to extinguish conditioned fear, DCS does not improve subsequent extinction to the same stimulus (Langton and Richardson, 2008).”
BackgroundThompson, L. T., & Disterhoft, J. F. (1997) · Behavioral Neuroscience · doi:10.1037/0735-7044.111.6.1303 · Cited by 57 · cited 3×
“, 2011), including auditory discrimination memory (Thompson and Disterhoft, 1997).”
BackgroundResultInfluentialDunn, M. J., & Killcross, S. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.08.028 · Cited by 31 · cited 1×
“Many forms of learning andmemory depend on NMDARs including auditory discrimination conditioning (Tan et al., 1989; Dunn and Killcross, 2006; Dix et al., 2010).”
Background
Cited by
Barnes, T. R., Drake, R., Paton, C., Cooper, S. J., Deakin, B., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 606
Glutamate hypothesis in schizophrenia
Uno, Y., & Coyle, J. T. (2019) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12823 · Cited by 367
Enhancement of psychosocial treatment with D-cycloserine: Models, moderators, and future directions
Otto, M. W., Kredlow, M. A., Smits, J. A. J., Hofmann, S. G., Tolin, D. F., de Kleine, R. A., van Minnen, A., Evins, A. E., & Pollack, M. H. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.09.007 · Cited by 70
Minichino, A., Brondino, N., Solmi, M., Del Giovane, C., Fusar-Poli, P., Burnet, P., Cipriani, A., & Lennox, B. R. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2020.02.012 · Cited by 50
Kuppili, P. P., Menon, V., Sathyanarayanan, G., Sarkar, S., & Andrade, C. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-020-02292-x · Cited by 16
Metadata
- Authors
- Cain, C. K., McCue, M., Bello, I., Creedon, T., Tang, D.-I., Laska, E., & Goff, D. C.
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 2014-03
- Volume
- 153
- Issue
- 1-3
- Pages
- 177-183
- ISSN
- 0920-9964 (ISSN-L)
- OpenAlex
- W2036522383
- Cited by
- 71
- References
- 23
- FWCI
- 6.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.